Clinical Trial Update: Phase II Study Evaluating the Clinical Efficacy and Safety of GN-037 in Plaque Psoriasis [Phase 2]

View source ↗

Summary

Phase II study evaluating the clinical efficacy and safety of GN-037 in plaque psoriasis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plaque Psoriasis

Drugs mentioned

• GN-037

Snippet

Sponsor: GEN İlaç ve Sağlık Ürünleri A.Ş. | Conditions: Psoriasis | Phase 2 | Status: COMPLETED